[1]陈瑞阳.双倍剂量氯吡格雷对心肌梗死患者经皮冠状动脉介入术后氯吡格雷抵抗的影响[J].新乡医学院学报,2018,35(8):716-718.[doi:10.7683/xxyxyxb.2018.08.017]
 CHEN Rui-yang.Effect of double dose of clopidogrel on clopidogrel resistance after percutaneous coronary intervention in patients with myocardial infarction[J].Journal of Xinxiang Medical University,2018,35(8):716-718.[doi:10.7683/xxyxyxb.2018.08.017]
点击复制

双倍剂量氯吡格雷对心肌梗死患者经皮冠状动脉介入术后氯吡格雷抵抗的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年8
页码:
716-718
栏目:
临床研究
出版日期:
2018-08-05

文章信息/Info

Title:
Effect of double dose of clopidogrel on clopidogrel resistance after percutaneous coronary intervention in patients with myocardial infarction
作者:
陈瑞阳
(长垣县人民医院心内科,河南 长垣 453400)
Author(s):
CHEN Rui-yang
(Department of Cardiology,the People′s Hospital of Changyuan County,Changyuan 453400,Henan Province,China)
关键词:
心肌梗死经皮冠状动脉介入术氯吡格雷抵抗氯吡格雷
Keywords:
myocardial infarctionpercutaneous coronary interventionclopidogrel resistanceclopidogrel
分类号:
R541.4
DOI:
10.7683/xxyxyxb.2018.08.017
文献标志码:
A
摘要:
目的 探讨双倍剂量氯吡格雷对心肌梗死患者药物洗脱支架经皮冠状动脉介入(PCI)术后氯吡格雷抵抗的影响。方法 将2010年6月至2017年6月长垣县人民医院收治的138例PCI术后氯吡格雷抵抗患者分为对照组和观察组,每组69例。2组患者术前均给予阿司匹林300 mg·d-1,服用1个月后改为100 mg·d-1,长期口服。对照组患者入院第2天起口服氯吡格雷75 mg·d-1,观察组患者入院第2天起口服氯吡格雷150 mg·d-1,服用1个月后改为75 mg·d-1,均长期维持治疗。比较2组患者治疗前、治疗7 d及1、3、6个月后二磷酸腺苷(ADP)诱导的血小板抑制率、术后6个月心血管事件和出血事件发生率。结果 治疗前2组患者ADP诱导的血小板抑制率比较差异无统计学意义(P>0.05);治疗后7 d及1、3、6个月观察组患者ADP诱导的血小板抑制率均高于对照组(P<0.05)。术后6个月,观察组与对照组患者心血管事件发生率分别为11.59%(8/69)和26.08%(18/69),观察组患者心血管事件发生率低于对照组(χ2=5.629,P<0.05);观察组和对照组患者出血事件发生率分别为11.59%(8/69)和14.49%(10/69),2组患者出血事件发生率比较差异无统计学意义(χ2=1.653,P>0.05)。结论 双倍剂量氯吡格雷能够有效降低心肌梗死PCI后氯吡格雷抵抗患者ADP诱导的血小板抑制率和心血管事件发生率。
Abstract:
Objective To investigate the effect of double-dose clopidogrel on clopidogrel resistance after percutaneous coronary intervention (PCI) with drug eluting stent in patients with myocardial infarction.Methods One hundred and thirty eight patients with clopidogrel resistance after PCI in the People′s Hospital of Changyuan County from June 2010 to June 2017 were selected as the study subjects.All the patients were divided into control group and observation group,with 69 cases in each group.The patients in the two groups were received 300 mg·d-1 aspirin before surgery,and the dose was changed to 100 mg·d-1 after one month of administration.The patients in the control group were received oral administration of 75 mg·d-1 clopidogrel from the second day after admission.The patients in the observation group were received oral administration of 150 mg·d-1 clopidogrel from the second day after admission,and the dose was changed to 75 mg·d-1 after one month.All the drugs were given for longperiods of time.The adenosine diphosphate (ADP) induced platelet inhibition rate was compared between the two groups before treatment and at seven days and one,three,six months after treatment.The incidence of cardiovascular events and bleeding events at 6 months after surgery were compared between the two groups.Results There was no significant difference in the ADP induced platelet inhibition rate between the two groups before treatment (P>0.05).The ADP induced platelet inhibition rate of the observation group was higher than that of the control group at seven days and one,three,six months after treatment (P<0.05).The incidence of cardiovascular events in the observation group and the control group at six months after operation was 11.59%(8/69) and 26.08%(18/69),respectively.The incidence of cardiovascular events in the observation group was lower than that in the control group at six months after operation(χ2=5.629,P<0.05).The incidence of bleeding events in the observation group and the control group at six months after operation was 11.59%(8/69)and 14.49%(10/69),respectively.There was no significant difference in the incidence of bleeding events between the two groups at six months after operation (χ2=1.653,P>0.05).Conclusion Double dose of clopidogrel can effectively reduce the ADP induced platelet inhibition rate and the incidence of cardiovascular events in patients with clopidogrel resistance after myocardial infarction.

参考文献/References:

[1] 张莹,苏敬泽,高铸烨,等.心肌梗死PCI术后患者焦虑抑郁状态的中医证候分布特点研究[J].世界中医药,2015,10(6):938-941.
[2] 李辉,许艳春.瑞舒伐他汀对PCI术后患者血管内皮功能、炎性因子的影响[J].海南医学院学报,2017,23(2):162-164.
[3] 夏裕,郑壁伟,李平宝,等.益气通痹汤对心肌梗死患者心功能及血管内皮功能的影响[J].世界中医药,2017,12(5):1021-1024.
[4] 杨佳,赵百孝,哈略,等.艾灸对动脉硬化模型ApoE-/-小鼠纤溶-凝血因子的调空作用研究[J].世界中医药,2016,11(8):1414-1418,1423.
[5] 詹晓燕,林玉蓓,胡杰,等.血栓弹力图监测冠心病患者PCI术后替格瑞洛和氯吡格雷抗血小板治疗效果研究[J].中国循证心血管医学杂志,2017,9(9):1108-1111.
[6] 林粦梅,林荣龙,蔡慧敏,等.血栓弹力图评价经PCI术后氯吡格雷及阿司匹林血小板抑制情况及作用机制[J].中国老年学杂志,2018,38(7):1568-1569.
[7] 陈瑞阳.不同血运重建方案下冠状动脉多支病变并发糖尿病高龄患者生存状况比较[J].新乡医学院学报,2017,34(6):500-502,506.
[8] REHMAN K U,AKHTAR T,SABAR M F,et al.Allele frequency distribution of CYP2C19*2 allelic variants associated with clopidogrel resistance in cardiac patients[J].Exp Ther Med,2015,10(1):309-315.
[9] LIN L,WANG H,CHEN Y F,et al.High maintenance dose of clopidogrel in patients with high on-treatment platelet reactivity after a percutaneous coronary intervention:a meta-analysis[J].Coronary Artery Dis,2015,26(5):386-395.
[10] 林乐健,唐发宽,华宁,等.双倍剂量氯吡格雷对老年患者介入术后心血管缺血事件及出血事件发生率的影响[J].中华老年心脑血管病杂志,2016,18(1):28-31.
[11] 张鹏博,张金盈.经皮冠状动脉介入术后不同剂量氯吡格雷治疗 CYP2C19基因中代谢型急性冠脉综合征的安全性研究[J].中国全科医学,2017,20(6):689-693.
[12] 魏雪梅,朱庆华,谷世奎,等.替格瑞洛在氯吡格雷抵抗急性心肌梗死患者PCI术后抗血小板治疗中的应用效果[J].山东医药,2015,55(15):46-47,48.
[13] 梁振洋,王海平,李毅,等.替格瑞洛与双倍剂量氯吡格雷治疗PCI术后血小板高反应性的单中心随机对照研究[J].中国循环杂志,2016,31(z1):54-54.
[14] 陈月,田辉,冯婉玉,等.双倍维持量氯吡格雷对经皮冠状动脉介入术后患者疗效和安全性的系统评价[J].中国临床药理学杂志,2017,33(10):951-953.

相似文献/References:

[1]郑晓晖,向铮,刘春平,等.早期无典型心电图改变的急性心肌梗死患者心电图及冠状动脉造影特点[J].新乡医学院学报,,():000.
[2]杨祖福,胡婉英,薛金贵,等.双龙丸对实验性心肌梗死大鼠血流动力学的影响[J].新乡医学院学报,2002,19(03):167.
[3]周书蕾,贾国印,崔自芳。.肺心病急性加重期合并心肌梗死5例分析[J].新乡医学院学报,2003,20(06):449.
[4]申金娥.急性心肌梗死59例急诊误诊分析 [J].新乡医学院学报,2004,21(01):000.
[5]刘有才.急性心肌梗死32例12~24h静脉溶栓治疗效果观察[J].新乡医学院学报,2005,22(02):155.
[6]刘慧杰1,常晓宾2,赵卫星3.miRNA与急性心肌梗死研究新进展[J].新乡医学院学报,2015,32(05):470.
[7]詹小娜,包恩泽,李贵华,等.替格瑞洛联合小剂量替罗非班对行急诊经皮冠状动脉介入术老年急性ST段抬高型心肌梗死患者梗死相关动脉血流及主要不良心血管事件的影响[J].新乡医学院学报,2018,35(7):584.[doi:10.7683/xxyxyxb.2018.07.009]
 ZHAN Xiao-na,BAO En-ze,LI Gui-hua,et al.Effect of ticagrelor combined with low dose tlrofiban on infarction artery blood flow & major adverse cardiovascular events elder patients with acute ST elevated myocardial infarction undergoing emerg[J].Journal of Xinxiang Medical University,2018,35(8):584.[doi:10.7683/xxyxyxb.2018.07.009]
[8]胡淋淋,马闻苛,李晓芳,等.胸段硬膜外阻滞对急性心肌梗死大鼠心肌细胞凋亡的影响[J].新乡医学院学报,2019,36(8):710.[doi:10.7683/xxyxyxb.2019.08.003]
 HU Lin-lin,MA Wen-ke,LI Xiao-fang,et al.Effect of thoracic epidural block on the cardiomyocyte apoptosis of rats with acute myocardial infarction[J].Journal of Xinxiang Medical University,2019,36(8):710.[doi:10.7683/xxyxyxb.2019.08.003]
[9]丁华永.血栓抽吸技术在经皮冠状动脉介入治疗急性前壁ST段抬高型心肌梗死老年患者中的应用价值[J].新乡医学院学报,2016,33(9):801.[doi:10.7683/xxyxyxb.2016.09.018]
 DING Hua-yong.Application of thrombus aspiration in elderly patients with acute anterior ST elevation myocardial infarction in percutaneous coronary intervention[J].Journal of Xinxiang Medical University,2016,33(8):801.[doi:10.7683/xxyxyxb.2016.09.018]
[10]崔 建.瑞舒伐他汀对不稳定型心绞痛患者经皮冠状动脉介入术后心肌损伤的保护作用[J].新乡医学院学报,2014,31(12):1042.[doi:10.7683/xxyxyxb.2014.12.023]
[11]张卫国.急性ST段抬高型心肌梗死患者血浆血红素加氧酶-1水平与急诊经皮冠状动脉介入术后无复流的关系[J].新乡医学院学报,2017,34(7):651.[doi:10.7683/xxyxyxb.2017.07.026]
 ZHAGN Wei-guo.Relationship between heme oxygenase-1 levels in patients with ST-segment elevation myocardial infarction and non-reflow after emergency percutaneous coronary intervention[J].Journal of Xinxiang Medical University,2017,34(8):651.[doi:10.7683/xxyxyxb.2017.07.026]

更新日期/Last Update: 2018-08-05